Improving colorectal cancer screening adherence in Barcelos and Esposende

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention project aims to enhance adherence to colorectal cancer screening among individuals aged 50 to 74 in Barcelos and Esposende. Participants will be randomly assigned to either an intervention group, which will receive two text messages and phone calls from both an administrative assistant and a physician, or a control group that will not receive these interventions. The study seeks to evaluate the effectiveness of these communication strategies in increasing screening rates for colon and rectal cancer. The trial is designed to gather data on the impact of proactive outreach on patient participation in screening programs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Participants must be registered in the ULS of

Barcelos/Esposende and meet the following criteria:

1. Age between 50 and 74 years.
2. No symptoms such as weight loss in the last 6 months or gastrointestinal symptoms.
3. No prior diagnosis of CRC.
4. No diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease).
5. No family history of CRC in first- and second-degree relatives diagnosed before age 60.
6. No prior fecal occult blood test (FOBT) in the 11 months before receiving the collection kit or no prior sigmoidoscopy or colonoscopy in the last 24 months.

Exclusion Criteria:

1. Participants who did not receive the screening kit at home.
2. Participants without a phone number.
3. Participants who do not answer the phone or refuse to participate in the study.
4. Participants unable to consent or perform the screening due to physical, mental, or other conditions that seriously impair comprehension.

Where it's running

• Public Health Unit Barcelos/Esposende
  Porto, Portugal Recruiting

Study contacts

• Study coordinator: Marina Barroso Pinheiro MD, PhD, PhD
• Email: mpinheiro@icbas.up.pt
• Phone: +351962654712

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• INV-8989 in KRAS G12D-mutant advanced solid tumors

  This study tests INV-8989 to see if it can be safely given and potentially help patients with KRAS G12D-mutant advanced solid tumors.

  Recruiting Phase 1/2 Shenzhen Ionova Life Sciences Co., Ltd. · Guangzhou, Guangdong · NCT07610798

• Combining gemcitabine, cisplatin, nab-paclitaxel and cemiplimab to shrink locally advanced biliary tract cancer

  This trial will try whether giving gemcitabine, cisplatin, nab-paclitaxel plus cemiplimab can shrink previously inoperable biliary tract cancers so surgery becomes possible.

  Recruiting Phase 2 Columbia University · New York, New York · NCT07433673

• Perioperative biomarker monitoring to spot complications after colorectal and gastric cancer surgery

  This randomized trial tests whether checking inflammatory and metabolic biomarkers during the perioperative period helps detect postoperative problems early in adults having colorectal or gastric cancer surgery.

  Recruiting Bucharest Emergency Hospital · Bucharest, Bucharest · NCT07881133

• Clonal Hematopoiesis Effects with Chemo and Radiation in Solid Cancers

  This study tests whether clonal hematopoiesis affects outcomes for adults with solid cancers who are receiving chemotherapy or radiation.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07675967

• BHB810 in advanced gastric and GEJ cancer (early-phase)

  This study tests whether BHB810 can be safely given every two weeks to adults with advanced gastric or GEJ adenocarcinoma and looks at its effect, how the drug behaves in the body, and patient responses.

  Recruiting at 2 sites Phase 1/2 BigHat Biosciences, Inc. · Duarte, California and 2 other locations · NCT07529808

• Biopsy and Resection Growth Patterns in Colorectal Peritoneal Cancer

  This study tests whether peritoneal growth patterns seen on small biopsies during staging laparoscopy match the patterns found in later surgical specimens for adults with colorectal peritoneal metastases.

  Recruiting Jules Bordet Institute · Brussels, Brussels Capital and 1 other locations · NCT07474025

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.